To facilitate precise genetic access to auditory circuits, we firstly developed a Scrt1 3 × HA‑P2A‑iCreER‑T2A‑EGFP knock‑in mouse model. This tool enables tamoxifen‑inducible, permanent labeling of Scrt1 ‑expressing cells. Systematic analysis from neonatal to adult stages revealed that Scrt1 is constitutively and specifically expressed in all type I spiral ganglion neurons (SGNs), with no detection in hair cells or type II SGNs. Furthermore, Scrt1 is expressed in neurons across all subdivisions of the cochlear nucleus (CN). These findings establish the Scrt1 ‑iCreER line as a potent genetic driver for targeting the primary sensory relay neurons in the auditory pathway. This model provides a valuable resource for mapping connectivity, monitoring activity, and functionally manipulating type I SGNs and their central targets in the CN, thereby advancing mechanistic studies of auditory processing and related disorders.
Mengya et al. (Thu,) studied this question.